Mirabella Financial Services LLP Inhibrx, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$26.75 - $46.02 $289,970 - $498,856
-10,840 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$25.18 - $37.81 $272,951 - $409,860
10,840 New
10,840 $361,000
Q4 2020

Feb 16, 2021
SELL
$15.96 - $50.0 $293,105 - $918,250
-18,365 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.77 - $20.65 $307,981 - $379,237
18,365 New
18,365 $331,000

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $565M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email